Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.

Regular exercise that follows established guidelines for physical activity in MS lead to clinically meaningful improvements ...

A person's total number of visits to multiple sclerosis clinics is not associated with a lower risk of death, a study on ...

A six-week music-based intervention may reduce psychosocial fatigue and heat pain sensitivity in people with multiple ...

An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...

Mesenchymal stem cell therapy lessens disability and brain lesions in MS patients, according to a review of published studies ...

Vibration therapy eases fatigue and improves motor and cognitive outcomes in MS, outperforming standard physical exercise ...

GFAP, or glial fibrillary acidic protein, supports star-shaped brain cells called astrocytes that help maintain nerve cell ...

People with MS visited doctors, were hospitalized, and used emergency care more than other people decades before their ...

Neural stem cell treatment was safe and significantly boosted myelin repair in spinal cord lesions in a mouse model of MS, ...